In our studies, high PLK1 level was also associated with clinical features such as grade, IDH mutation status, 1p/19q co-deleted status, and methylation status of MGMT promoter in glioma (Supplementary Figure 2). The gene discussed is IDH1; the disease is central nervous system cancer.